Open Access

Multidimensional effects of biologically synthesized silver nanoparticles in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma A549 cells

Nanoscale Research Letters201510:35

Received: 8 December 2014

Accepted: 10 January 2015

Published: 5 February 2015


Silver nanoparticles (AgNPs) are prominent group of nanomaterials and are recognized for their diverse applications in various health sectors. This study aimed to synthesize the AgNPs using the leaf extract of Artemisia princeps as a bio-reductant. Furthermore, we evaluated the multidimensional effect of the biologically synthesized AgNPs in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma (A549) cells. UV-visible (UV–vis) spectroscopy confirmed the synthesis of AgNPs. X-ray diffraction (XRD) indicated that the AgNPs are specifically indexed to a crystal structure. The results from Fourier transform infrared spectroscopy (FTIR) indicate that biomolecules are involved in the synthesis and stabilization of AgNPs. Dynamic light scattering (DLS) studies showed the average size distribution of the particle between 10 and 40 nm, and transmission electron microscopy (TEM) confirmed that the AgNPs were significantly well separated and spherical with an average size of 20 nm. AgNPs caused dose-dependent decrease in cell viability and biofilm formation and increase in reactive oxygen species (ROS) generation and DNA fragmentation in H. pylori and H. felis. Furthermore, AgNPs induced mitochondrial-mediated apoptosis in A549 cells; conversely, AgNPs had no significant effects on L132 cells. The results from this study suggest that AgNPs could cause cell-specific apoptosis in mammalian cells. Our findings demonstrate that this environmentally friendly method for the synthesis of AgNPs and that the prepared AgNPs have multidimensional effects such as anti-bacterial and anti-biofilm activity against H. pylori and H. felis and also cytotoxic effects against human cancer cells. This report describes comprehensively the effects of AgNPs on bacteria and mammalian cells. We believe that biologically synthesized AgNPs will open a new avenue towards various biotechnological and biomedical applications in the near future.


Silver nanoparticles Helicobacter pylori Helicobacter felis Human lung cells Lung carcinoma cells Cell viability ROS Mitochondrial membrane potential


Nanomaterials often have novel and size-related physico-chemical properties that differ significantly from their larger counterparts. Therefore, the growing interest in the field has driven the production of numerous nanomaterials with outstanding optical, magnetic, catalytic, and electrical properties [1,2]. Silver nanoparticles (AgNPs) have become increasingly popular and have been used in various applications such as antibiotic agents in textiles and wound dressings and in biomedical devices; furthermore, they are one of the most commonly used engineered nanoparticles in commercialized products [3,4]. Since AgNPs have widespread applications, academia and industry have paid more attention to the production of AgNPs than to their uses [5].

Among several methods, chemical methods provide an easy way to synthesize AgNPs in solution, and they are a commonly used method for the production of AgNPs [5]. In contrast, physical methods appear to produce a low yield. Chemical methods, on the other hand, are more complex in that they require three main components, including metal precursors, reducing agents, and stabilizing/capping agents. Furthermore, chemical methods use various toxic materials including hydrazine, citrate, borohydride, or other organic compounds (e.g., reducing agents); all these agents can be toxic to living organisms including humans. Capping agents are playing an important role for the stabilization of nanoparticles, for example, capped AgNPs exhibit better antibacterial activity than uncapped AgNPs do [6,7]. Biological methods seem to be valuable for the preparation of AgNPs with controlled size and shape of the nanoparticles [8-13]. Given that conventional physical methods have low yields and chemical methods are toxic and consume a lot of energy, the development of environmentally friendly approaches has become the more preferred trend for the field of nanobiotechnology. Biologically prepared nanomaterials are extremely valuable because nanoparticles are easily soluble and stable [14]. In addition, during the biological synthesis of AgNPs, the reducing agent and stabilizer are replaced by molecules produced by living organisms. These molecular compounds can be sourced from various living organisms such as bacteria, fungi, yeasts, algae, or plants [15]. Biomolecules can be attached to various types of surfaces via diffusion, adsorption/absorption, covalent cross-linking, and affinity interaction [16].

Recently, numerous microorganisms have been reported to synthesize AgNPs, including bacteria like Pseudomonas stutzeri AG259 [17], Bacillus licheniformis [10], Brevibacterium casei [18], Escherichia coli [9], and Shewanella oneidensis [19] and fungi like Fusarium oxysporum [20], Trichoderma viride [21], and Ganoderma neo-japonicum [21]. Extracellular synthesis of various types of nanoparticles was performed using plants, including geranium leaves [22] and lemongrass [23], via the reduction of aqueous AgNO3 and AuCl4, respectively. Previous studies suggest that leaf and other parts of plant extracts from various plants, such as Azadirachta indica [24], Aloe vera [25], Bryophyllum sp. [26], Gliricidia sepium, Alfalfa sprouts [27,28], aqueous stem extract of banana [29], and Allophylus cobbe [8], have also been explored for the synthesis of AgNPs. Compared to other reducing agents derived from microorganisms, the reduction of the Ag+ ions with the extracts of plants occurs quickly [22]. Furthermore, biological methods seem to have less time required for complete reduction and be stable and readily available in solution at high densities [13]. Similarly, shape and size, the rate of reduction of metal ions is faster, and more stable metal nanoparticles are formed using leaf extracts compared to using microorganisms [28,30].

The green juice of Artemisia princeps used to treat skin injuries and gastrointestinal disorders [31,32]. Yun et al. [33] have identified 16 water-soluble phenolic compounds in the leaf water extract of A. princeps, and its extract contains 192 volatile chemicals [31]. Therefore, this plant extract can be used as a reducing and stabilizing agent for the synthesis of AgNPs.

Infections caused by multidrug-resistant bacteria lead to major public health issues, such as morbidity, mortality, cost of health care, and the need for implementation of infection control measures [34]. Parsonnet et al. [35] reported that bacteria have been linked to cancer by the induction of chronic inflammation and the production of carcinogenic bacterial metabolites. A pertinent example of the inflammatory mechanism of carcinogenesis is the Helicobacter pylori infection. H. pylori are known to cause infection in the stomach and are found in about two thirds of the world’s population. H. pylori exist and are adherent to the epithelium of stomach. Non-pylori gastric Helicobacter organisms cause chronic gastritis and inflammation in humans [36]. On the other hand, Fusobacterium nucleatum promotes colorectal carcinogenesis and intestinal tumorigenesis and modulates the tumor-immune microenvironment [37,38].

Recent surveys suggest that lung cancer accounts for 23% of all cancer-related mortality, outnumbering the total mortality of breast, colon, and prostate cancers combined [39,40]. To address the effect of AgNPs, several studies have reported the impact of AgNPs in various cell lines, such as BRL4A rat liver cells [41], PC-12 neuroendocrine cells [42], germ line stem cells [43], rat alveolar macrophages [44], and a human lung carcinoma cell line, A549 [45]. Recent studies reported that biologically prepared AgNPs have been used for antibacterial and antifungal [46-48]. The results from previous studies suggest that the generation of reactive oxygen species (ROS) is an important and general mechanism of nanoparticle-mediated cytotoxicity through DNA damage, apoptosis, and necrosis [44,49-53]. Although various studies have addressed the effect of AgNPs in various cell lines, there has been no study on the multiple functions of biologically prepared AgNPs using A. princeps on bacteria causing carcinogenesis and human cancer cells. Therefore, this study was aimed to investigate the following objectives. Firstly, we aimed to develop an easy, consistent, cost-effective, and green approach to the synthesis of colloidal AgNPs using leaf extract of A. princeps. Secondly, we evaluated the antibacterial and anti-biofilm activity of AgNPs against H. pylori and non-pylori Helicobacter felis. Finally, we assessed the cell-specific cytotoxic effects of AgNPs in normal lung and lung cancer cells.


Bacterial strains and reagents

All culture media and chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated. The strains of H. pylori GS-13 and H. felis GS-14 used in the present study were obtained from our culture collection. All strains were maintained at −80°C in Brucella agar (BA) (Sigma, Cream Ridge, NJ, USA) supplemented with 2% fetal calf serum (FCS). Penicillin-streptomycin solution, trypsin-EDTA solution, RPMI 1640 medium, and 1% antibiotic-antimycotic solution were obtained from Life Technologies/Gibco (Grand Island, NY, USA). Silver nitrate, fetal bovine serum (FBS), and the in vitro toxicology assay kit were purchased from Sigma-Aldrich (St. Louis, MO, USA).

Synthesis and characterization of AgNPs

A. princeps leaves were collected from plants growing in the Jeju Island, South Korea, and stored at 4°C until needed. The leaf extract was prepared according to method described earlier [54]. Briefly, the filtered extract was used for the synthesis of AgNPs by adding 10 mL (1 mg/mL) to 100 mL of 1 mM AgNO3 in an aqueous solution at room temperature. The bio-reduction of the AgNO3 was monitored spectrophotometrically between 300 and 600 nm. The synthesized particles were characterized according to methods described previously [9]. The size distribution of the dispersed particles was measured using a Zetasizer Nano ZS90 (Malvern Instruments Ltd., Malvern, UK). X-ray diffraction (XRD) analyses were carried out on an X-ray diffractometer (Bruker D8 DISCOVER; Bruker AXS GmBH, Karlsruhe, Germany). The high-resolution XRD patterns were measured at 3 Kw with a Cu target using a scintillation counter (λ = 1.5406 °A) at 40 kV and 40 mA and were recorded in the range of 2θ = 5°–80°. Further characterization of changes in the surface and surface composition was performed by Fourier transform infrared spectroscopy (PerkinElmer Spectroscopy GX, PerkinElmer, Waltham, MA, USA). Transmission electron microscopy (TEM), using a JEM-1200EX microscope, was performed to determine the size and morphology of AgNPs. TEM images of AgNPs were obtained at an accelerating voltage of 300 kV.

Determination of minimum inhibitory concentrations of AgNPs and in vitro killing assay

Minimal inhibitory concentration (MIC) of H. pylori and H. felis was determined as described previously [8]. To determine the MICs of AgNPs, H. pylori and H. felis were then exposed to different concentrations of AgNPs. Growth was monitored using a microtiter ELISA reader (EMax, Molecular Devices, Sunnyvale, CA, USA) by monitoring the absorbance at 600 nm. The MIC of AgNPs was defined as the lowest concentration that inhibited the visible growth of bacteria. The in vitro killing assay was performed as described previously [8].

Determination of biofilm activity using the tissue culture plate method

Inhibition of biofilm was determined as described earlier with suitable modifications [8,55]. Briefly, the cells were grown in Brucella broth supplemented with 2% FCS and individual wells of sterile, 96-well flat-bottom polystyrene tissue culture plates (TCPs) were filled with 180 μL of a single bacterial species (1 × 106/mL). The cell culture plates were then incubated with AgNPs for 24 h at 37°C. After incubation, the media were removed, and the wells were washed three times with 200 μL sterile distilled water to remove non-adherent bacteria. The crystal violet solutions in water were added for 45 min. The wells were then washed five times with 300 μL of sterile distilled water to remove excess stain. The absorbance of each well was measured at 595 nm using a microtiter ELISA reader. The percent inhibition of biofilm activity was calculated as described earlier [8,55].

Measurement of ROS generation in bacteria

ROS was determined according to the manufacturer’s instructions and according to previous publications [8,49,56]. All test strains were grown in BB. Cell suspensions were incubated with AgNPs at 37°C on a rotary shaker for 12 h. Aliquots were then removed and spun in a microfuge, and the absorption of the supernatant was measured at 450 nm.

Cell culture

Human lung cancer A549 cells and normal human lung L-132 cells were obtained from the Korean Cell Bank (Seoul, Korea) and cultured in RPMI 1640 medium supplemented with 10% FBS and 100 U/mL penicillin-streptomycin at 5% CO2 and 37°C. At 75% confluence, the cells were harvested using 0.25% trypsin and subcultured in 75-cm2 flasks, 6-well plates, or 96-well plates. Cells were allowed to attach the surface for 24 h before treatment. The medium was replaced three times per week, and the cells were passaged at subconfluency.

Cell viability and cytotoxicity assays

Cell viability was measured using a Cell Counting Kit-8 (CCK-8; Dojindo Laboratories, Kumamoto, Japan). Briefly, A549 and L132 cells were plated onto 96-well flat-bottom culture plates with various concentrations of AgNPs. All cultures were incubated for 24 h at 37°C (5% CO2 in a humidified incubator). CCK-8 solution (10 μL) was added to each well, and the plate was incubated for another 2 h at 37°C. Absorbance was measured at 450 nm with a microplate reader (Multiskan FC; Thermo Fisher Scientific Inc., Waltham, MA, USA). Cytotoxicity was assessed using supernatants from the medium in lactate dehydrogenase (LDH) assays. An LDH Cytotoxicity Detection kit (Takara Bio Inc., Tokyo, Japan) was used according to the manufacturer’s protocol, and the absorbance was measured at 490 nm using a microplate reader.

ROS (H2-DCFH-DA) assay

Human lung normal L132 cells and A549 human lung epithelial adenocarcinoma cells were cultured in minimum essential medium (Hyclone Laboratories, Logan, UT, USA) containing 10 μM H2-DCFDA in a humidified incubator at 37°C for 30 min. Cells were washed in PBS (pH 7.4) and lysed in lysis buffer (25 mM HEPES [pH 7.4], 100 mM NaCl, 1 mM EDTA, 5 mM MgCl2, and 0.1 mM DTT supplemented with a protease inhibitor cocktail). Cells were cultured on coverslips in a 4-well plate. Cells were incubated in DMEM containing 10 μM H2-DCFDA at 37°C for 30 min. Cells were washed in PBS, mounted with Vectashield fluorescent medium, and viewed with a fluorescence microscope.

JC-1 assay

The change in mitochondrial transmembrane potential was evaluated using the cationic fluorescent indicator JC-1 (Molecular Probes, Eugene, OR, USA). J-aggregates of intact mitochondria were fluorescent red with an emission at 583 nm, and J-monomers in the cytoplasm were fluorescent green with emission at 525 nm and an excitation wavelength of 488 nm. A549 and L132 cells were incubated in RPMI containing 10 μM JC-1 at 37°C for 15 min, washed with PBS, and transferred to a clear 96-well plate. Cells were also cultured on cover slips, incubated in DMEM containing 10 μM JC-1 at 37°C for 15 min, and then washed with PBS. Finally, cells were mounted using Vectashield fluorescent medium and visualized with fluorescence microscopy.

Statistical analyses

All assays were carried out in triplicate and the experiments were repeated at least three times. The results are presented as means ± SD. All experimental data were compared using Student’s t-test. A p value less than 0.05 was considered statistically significant.

Results and discussion

Synthesis and characterization of AgNPs using leaf extract

Synthesis of AgNPs using leaf extract was performed according to a previously described method [8]. The leaf extract of A. princeps was used as both a reducing and stabilizing agent. In a typical reaction procedure, 10 mL of A. princeps leaf extract was added to 100 mL of 1 mM aqueous AgNO3 solution under magnetic stirring at room temperature for 60 min. The color change was observed by visual observation in the tube, which contains AgNO3 solution with leaf extract. The mixture of silver nitrate and leaf extract changed rapidly from green to a brown suspended mixture after 15 min, whereas silver nitrate without leaf extract exhibited no color change (Figure 1 inset). The synthesis of AgNPs using the leaf extract was confirmed by the color change. To monitor the synthesis and stability of AgNPs, the absorption spectra of the AgNPs were observed using UV-visible spectroscopy. The color of the solutions changed from pale yellow to yellowish brown to deep brown depending on the extract concentration; this indicates that AgNP formation occurs due to the excitation of surface plasmon vibration (SPR) of the particles. The typical SPR of AgNPs was observed between 410 and 420 nm (Figure 1).
Figure 1

Synthesis and characterization of AgNPs using leaf extract of A. princeps. The inset shows tubes containing samples of silver nitrate (AgNO3) after exposure to 60 min (1), leaf extract (2), and AgNO3 plus leaf extract (3). The color of the solution turned from pale yellow to brown after 15 min of incubation, indicating the formation of silver nanoparticles. The absorption spectrum of AgNPs synthesized by leaf extract exhibited a strong broad peak at 410 nm, and observation of such a band is assigned to surface plasmon resonance of the particles.

XRD analysis of AgNPs

The crystalline nature of the AgNPs was confirmed using XRD, and the XRD pattern revealed Bragg’s reflections that represent the face-centered cubic structure of silver. Figure 2 shows the XRD patterns of dried AgNPs synthesized with A. princeps leaf extract. The XRD patterns indicated that the structure of AgNPs is face-centered cubic (fcc) [8,57]. The sharp XRD peaks at 2θ of 31.9 and 45.3 are attributed to the (111) and (200) crystallographic planes. The two diffraction peaks could be indexed as (111), (200), (220), (311), and (222) planes of fcc silver (JCPDS, fileno.04-0783) [24]. A comparison made between our XRD spectrum and the standard confirmed that our silver particles exhibited Bragg’s reflections of silver. Hence, the XRD results clearly show that the AgNPs are crystalline. Interestingly, the XRD pattern shows no impurities as reported earlier [58]. From the XRD data and the use of the Debye-Scherer equation, the average particle size was 20 ± 3.5 nm. Remarkably, the absence of peaks from other phases suggests that nanoparticles with single-phase Ag with cubic structure were synthesized. Awwad et al. [58] reported that using carob leaf extract as a reducing and stabilizing agent produced 5- to 50-nm sizes of AgNPs. Recently, Mukherjee et al. [59] reported that the AgNPs synthesized with leaf extract from Olax scandens were mostly monodispersed and spherical (20 to 60 nm) along with very few larger particles (approximately 90 nm). Our studies suggest that A. princeps shows a significantly uniform distribution of particles with an average size of 20 nm.
Figure 2

XRD pattern of AgNPs. A representative X-ray diffraction (XRD) pattern of silver nanoparticles formed after reaction of leaf extract with 1 mM of silver nitrate (AgNO3) for 60 min at 60°C. The XRD pattern shows two intense peaks in the whole spectrum of 2θ values ranging from 20 to 70. The intense peaks were observed at 2θ values of 31.9 and 45.31 corresponding to (111) and (200) planes for silver, respectively.

FTIR spectra of AgNPs

To identify the possible biomolecules involved in the reduction of the Ag+ by the extract of leaf broth, we used Fourier transform infrared spectroscopy (FTIR) measurements [22]. The silver nitrate solution after completing the reduction of Ag+ ions and the formation of AgNPs was centrifuged at 10,000 rpm for 15 min to isolate the AgNPs from free proteins [22]. The FTIR spectrum of AgNPs exhibits peaks at 1,727 and 1,638 cm−1 that are attributed to ester CdO groups of chlorophyll [22,60]. It is well known that water-soluble fractions of A. princeps leaves contain large amounts of secondary metabolites; these secondary metabolites may favor the synthesis of nanoparticles as reducing agents [31]. Terpenoids possibly contribute to the reduction of the silver ions that, in the process, are oxidized to carbonyl groups, resulting in a band at 1,727 cm−1. During the formation of AgNPs, the peak corresponding to the amide I band at 1,638 cm−1 broadened, which indicates capping of the AgNPs by protein (Figure 3). The absorption peak at 1,638 cm−1 may be ascribed to the carbonyl stretch in proteins, while the peaks at 3,398 cm−1 represent the OH stretching in alcohols and phenolic compounds [61-63]. The strong intense peaks at 1,387 and 1,638 cm−1 correspond to C-N stretch vibrations, as well as to the amide I bands of proteins in the leaf extract. The absorption peak at 1,638 cm−1 is close to that reported for native proteins [64]. This suggests that proteins are interacting with biosynthesized nanoparticles, and their secondary structure were not affected during the reaction with Ag+ ions. Proteins are able to bind with silver or gold nanoparticles either through free amine groups or cysteine residues in the proteins [65]. A similar mechanism may be involved when the leaf extract from A. princeps caps the AgNPs, thereby stabilizing the particles. Similarly, several other researchers found a similar FTIR pattern of AgNPs using geranium leaf extract [22], Ocimum sanctum leaf extract [66,67], and Camellia sinensis [62]. The results obtained from FTIR spectroscopy suggest that the leaf extracts have the ability to reduce and stabilize the AgNPs. The present results agree with those reported previously for Rhinacanthus nasutus [68], Thevetia peruviana [69], latex of Jatrophacurcas [67], O. sanctum leaf extract [63,66], and C. sinensis [62].
Figure 3

FT-IR spectrum of silver nanoparticles synthesized by treating AgNO 3 with leaf extract.

Dynamic light scattering analysis of AgNPs

Dynamic light scattering (DLS) measurement was used to determine the size of synthesized AgNPs in aqueous solution. Powers et al. [70] proposed DLS to be one of the most valuable and useful technique to evaluate particle size and size distribution of any nanomaterial in solution [71]. Specifically, particle size, size distribution, particle morphology, particle composition, surface area, surface chemistry, and particle reactivity in solution are important factors to assess the nanoparticle toxicity [72]. DLS characterizes the size of colloidal dispersions using the illumination of a particle or molecule suspension undergoing Brownian motion by a laser beam [72]. The present study used DLS, in conjunction with TEM, to evaluate the size distribution. The DLS pattern revealed that the synthesized AgNPs showed an average size of 40 ± 15 nm (Figure 4). From the figure, the particles obtained were monodisperse in the range 10 to 100 nm and had an average size of 40 nm. This size is larger than the TEM data, which is due to the hydrodynamic size of nanomaterials. Singhal et al. [63] reported that the AgNPs synthesized using O. sanctum leaf extract showed an average diameter of 22.38 nm. Umoren et al. [72] reported that the average size of the synthesized AgNPs using red apple fruit extract is around 150 nm. The sizes and shapes of metal nanoparticles are influenced by a number of factors, including pH, precursor concentration, reductant concentration, time of incubation, temperature, and the method of preparation [9].
Figure 4

Size distribution analysis by dynamic light scattering (DLS). Silver nanoparticles were dispersed in deionized water and the particles were mixed thoroughly via sonication and vortexing, and samples were measured at 25 μg/mL.

Size and surface analysis of AgNPs by TEM

TEM is widely used to directly and accurately analyze the structural and size information of nanoparticles. TEM was used to characterize the nanoparticle sizes and morphologies [71]. Next, we examined the size and surface morphologies of synthesized AgNPs. TEM micrographs of AgNPs show distinct, uniform, and spherical nanoparticles that were widely separated. The average particle size was estimated from more than 300 particles and determined to be between 5 and 30 nm with an average size of 20 nm (Figure 5A). It was observed that AgNPs were evenly distributed in the analyzed sample (Figure 5B). Shankar et al. [22] reported that the size of the nanoparticles produced by geranium leaf extract from 16 to 40 nm. Mukherjee et al. [59] reported that synthesized AgNPs using O. scandens leaf extract shows almost monodispersed spherical nanoparticles (20 to 60 nm) along with very few bigger particles (approximately 90 nm). Interestingly, our data suggest that using A. princeps could produce smaller AgNPs, which are better for antimicrobial activity and anticancer activity. The image obtained from TEM study shows that the morphology of AgNPs is spherical, which is in agreement with the shape of the SPR band in the UV-visible (UV–vis) spectrum. The particle size could be controlled by varying the parameters such as temperature, pH, and concentration of AgNO3 [9].
Figure 5

Size and surface morphology of AgNPs analysis by TEM. (A) Several fields were photographed and used to determine the diameter of silver nanoparticles (AgNPs) using TEM. The average range of observed diameter was 20 nm. (B) Histogram of Particle size from transmission electron microscopy images.

Determination of MIC of AgNPs against H. pylori and H. felis

In response to the overwhelming evidence linking H. pylori infection to human cancer, the International Agency for Research on Cancer listed H. pylori as a definite human oncogenic agent in 1994 [36,73-75]. Therefore, we were interested in finding out the MIC of AgNPs against both pylori and non-pylori strains, such as H. pylori and H. felis, respectively. The MIC of AgNPs was defined as the lowest concentration that completely inhibited visible growth of bacteria after incubation at 37°C for 24 h. In these studies, H. pylori and H. felis were used as a model bacteria for Gram negative to evaluate antibacterial activities of AgNPs. Both strains were incubated with the different concentration of AgNPs for 24 h in Brucella broth. The media without AgNPs were used as a control. The H. pylori and H. felis bacterial counts were significantly reduced by the treatment with AgNPs than control. The level of MIC of AgNPs was found to be 5.0 and 5.5 μg/mL to H. pylori and H. felis, respectively. The toxic effects of AgNPs depend on size, surface area, and surface functionalization which are major factors that influence bio-kinetics and toxicity in bacteria [76,77].

Dose-dependent antibacterial effects of AgNPs

The antimicrobial effect of Ag+ ions has been well documented and it has been applied [78,79]. We are interested to investigate the potential of antibacterial activity of biologically synthesized AgNPs against H. pylori and H. felis. The dose-dependent antibacterial activity of AgNPs was determined using representative Gram-negative bacterial strains, H. pylori, and H. felis. Figure 6 shows the toxicity of biologically synthesized AgNPs (20 nm) at concentrations of 0.01 to 5 μg/mL to H. pylori and H. felis. Cell viability was reduced as the concentrations of the AgNPs increased [8]. For each bacterial strain, no growth was observed at their respective MIC values. Thus, these represent bactericidal concentrations for each specific bacterial strain. The plant extract-mediated AgNPs exhibited significant antimicrobial activity. For example, Li et al. [80] reported that 10 μg/mL (AgNPs) could completely inhibit the growth of 107 CFUs/mL of E. coli in liquid MHB. Anthony et al. [81] reported that 10 μg/mL treatments of AgNPs with an average size of 40 nm decreased the cell viability completely in Pseudomonas aeruginosa. Kim et al. [76] investigated the antimicrobial activity of Ag nanoparticles against bacteria and yeast, and they found that E. coli shows more sensitivity at low concentration of Ag nanoparticles, whereas the effects of AgNPs on Staphylococcus aureus were mild. Our studies show that a promising inhibitory effect of AgNPs against tested strains was observed with concentration of 5 μg/mL. Previous studies showed that AgNPs are effective antimicrobial agents and mechanisms of toxicity attached with cell membrane and disturb their functions such as permeability and respiration [77,82-84]. Our results suggest that AgNPs synthesized using plant extract of A. princeps seem to be smaller in size, which may provide more bactericidal effects than larger particles.
Figure 6

Effect of AgNPs on cell survival of H. pylori and H. felis. Dose-dependent effects of AgNPs on bacterial survival. All test strains were incubated in the presence of different concentrations of AgNPs. Bacterial survival was determined at 4 h by a CFU assay.

Time-dependent antibacterial activity of AgNPs

The time-dependent antibacterial efficiency of AgNPs was determined in H. pylori and H. felis. The loss of viability of H. pylori and H. felis was counted at different time points such as 1, 2, 3, and 4 h (Figure 7). The loss of H. pylori viability increased after 1-h incubation with AgNPs from 1.2 to 1.0 optical density, whereas H. felis shows a weak difference between treated and untreated; however, both strains showed a sharp decrease of growth from 1.0 to 0.6. By increasing the time of incubation, the loss of viability increased after 3 to 4 h of incubation. The division of cell death occurred in all 4 h of incubation; however, a large fraction of cell death occurred in the earlier hour of incubation. The treated groups show significant growth defect than control, whereas both control strains show health and no significant growth impairment.
Figure 7

Time-dependent effect of AgNPs on H. pylori and H. felis. Time-dependent effects of AgNPs on bacterial survival. All test strains were incubated in the presence of different concentrations of AgNPs. Bacterial survival was determined at 4 h by a CFU assay.

Anti-biofilm activity of AgNPs against H. pylori

Biofilms are surface-bound communities of microbial cells found in oligotrophic environments and are strongly implicated in bacterial virulence [55,85]. Yonezawa et al. [55] reported the biofilm activity of H. pylori. However, the anti-biofilm activity of AgNPs against H. pylori is recognized that it is still in its infancy. The purpose of the experiment was to design to investigate the inhibitory effects of AgNPs on biofilm formation by H. pylori. In this experiment, tissue culture plate was to assess the effect of AgNPs on inhibition of biofilm formation by H. pylori. Previously, we reported the antibacterial and anti-biofilm effects of AgNPs in P. aeruginosa [86]; therefore, this study was aimed to investigate the dose-dependent ability of AgNPs to inhibit the activity of biofilms by the human pathogen H. pylori, which is an unexplored microorganism. All test strains were grown for 24 h in microtiter plate wells and then treated with concentrations of AgNPs of 0.01 to 5 μg/mL (Figure 8). Treatment of H. pylori and H. felis for 24 h with 5 μg/mL of AgNPs shows decreased biofilm activity by more than 90 to 95%. Kalishwaralal et al. [86] reported that AgNPs inhibit biofilm formation against P. aeruginosa and Staphylococcus epidermidis using 100 nM of AgNPs which resulted in a 95 to 98% reduction in biofilm formation. Ansari et al. [87] demonstrated that AgNPs are able to inhibit production of exopolysaccharides, which are essential for biofilm formation. AgNPs also enhanced quorum quenching activity against S. aureus biofilm and prevention of biofilm formation [88]. Martinez-Gutierrez et al. [89] demonstrated that AgNPs could effectively prevent the formation of biofilms and kill bacteria in established biofilms. Taken together, our studies suggest that leaf extract A. princeps-mediated synthesis of AgNPs could be a viable anti-biofilm agent.
Figure 8

Anti-biofilm activity of AgNPs. The anti-biofilm activity of AgNPs was assessed by incubating all test strains with different concentrations of AgNPs for 24 h in a 96-well plate. The results are expressed as the mean ± SD of three separate experiments each of which contained three replicates. Treated groups showed statistically significant differences from the control group by Student’s t-test (p < 0.05).

Effect of AgNPs on ROS production

To investigate the effect of AgNPs on ROS production, which is one of the key factors for bacterial cell death, H. pylori and H. felis were selected as a model bacterium to study the effect of ROS released from the surface of AgNPs on cell death. The bacterial cells were incubated with AgNPs for 12 h and then we measured the ROS production. The levels of ROS in AgNP- or H2O2-treated cells were higher, compared to the level of ROS in control cells [56]. H2O2 led to slightly higher ROS levels compared to the level of ROS in the AgNP-treated cells. Further, we tested if pre-incubation of cells with GSH or NAC could prevent ROS generation by AgNPs and found that these intracellular antioxidants protected H. pylori and H. felis from AgNPs and H2O2 (Figure 9). The data obtained from this study suggest that cell death is mediated by ROS production, which might alter the cellular redox status [56].
Figure 9

Effect of AgNPs on the generation of ROS. All test strains were treated with 1 μg/mL AgNPs for 12 h. ROS generation was measured by the XTT assay. The results are expressed as the means ± SD of three separate experiments, each of which contained three replicates. Treated groups showed statistically significant differences from the control group by Student’s t-test (p < 0.05).

ROS is a natural by-product of the metabolism of respiring organisms [76]. Induction of ROS synthesis leads to the formation of highly reactive radicals that destroy the cells. The possible mechanisms of H. pylori and H. felis cell death are due to membrane damage by AgNPs which relates to metal depletion, that is, the formation of pits in the outer membrane and change in membrane permeability by the progressive release of lipopolysaccharide (LPS) molecules and membrane proteins [90]. Previous studies proposed that the sites of interaction for AgNPs and membrane cells might be due to sulfur-containing proteins present in the bacterial membrane proteins [91-95]. Previous studies suggest that ROS may be a common mechanism of cell death induced by bactericidal antibiotics [96-99].

DNA fragmentation

Apoptotic cell death is essential to the development and long-term viability of multicellular organisms [96,100,101]. Apoptosis can be induced in response to variety of intra and extracellular stimuli and stresses. A characteristic feature of apoptosis is the cumulative effects of biochemical and morphological changes which include cell-cycle arrest, halt DNA repair and homeostasis, inactivate apoptosis inhibitor proteins, and facilitate ultra-structural modifications, breakdown of cellular contents, and marking for death [96,102]. Previously, several studies shows that bactericidal antibiotics induces the generation of ROS, via a common metabolic mechanism, which contributes to drug-induced killing [98,103,104], which is due to production of ROS. Furthermore, Dwyer et al. [96] demonstrated that drug-induced bacterial cell death is indeed accompanied by DNA fragmentation, chromosomal condensation, and loss of structural integrity, all markers of eukaryotic apoptosis. We are interested to determine whether AgNPs could induce DNA fragmentation, which are physiological hallmarks of apoptosis in bacteria. To examine whether ROS generation by AgNPs leads to DNA damage in H. pylori and H. felis, DNA was extracted from both AgNP (1 μg/mL) treated cells with of AgNPs for 12 h and analyzed for the occurrence of DNA fragmentation. The results show that both strains treated with AgNPs for 12 h show laddering of DNA, specific DNA smearing is a characteristic feature of cell death [56], whereas untreated groups did not show significant fragmentation (Figure 10), which suggests that AgNPs are able to induce fragmentation of DNA free radicals produced by AgNPs. It is known that intracellular oxidative stress could be accelerated by NPs by disturbing the equilibrium between the oxidant and antioxidant processes [77]. ROS typically includes the superoxide radical (O2−), hydrogen peroxide (H2O2), and hydroxyl radical (OH), which cause damage to cellular components, including DNA and proteins [105,106]. ROS induces mitochondrial membrane permeability and damages the respiratory chain to trigger the apoptotic process [107]. The results drawn from DNA smearing studies indicate that AgNPs derived from A. princeps one of the potent inducer of ROS and eventually this ROS generation induces DNA fragmentation of cells. Although several studies have reported the antibacterial activity of biologically synthesized AgNPs in several microorganisms, this report describes that the maximum antibacterial and anti-biofilm effect with the lowest concentration of AgNPs in H. pylori and H. felis.
Figure 10

Detection of AgNP-induced apoptosis by DNA fragmentation. For DNA fragmentation analysis, cells were treated with 1 μg/mL for 12 h. After incubation, DNA extracted from cells and resolved on agarose gel electrophoresis. Lane 1, 1 kB ladder; lane 2, control from H. pylori; lane 3, control from H. felis; lane 4, 1 kB ladder; lane 5, AgNP-treated H. pylori; lane 6, AgNP-treated H. felix.

Effect of AgNPs on cell viability of L132 and A549 cells

Although several studies showed the potential toxicity of AgNPs in cancer cells [51,54], to see the cell-specific activity of AgNPs, the effects of AgNPs on cell viability were evaluated using human lung cancer A549 cells and normal human lung L-132 cells; we selected A549 cancer cells and L-132 normal cells for our study because entry through the respiratory tract is one of the most frequent routes by which nanomaterials may enter the body. It was also to compare the cytotoxicity of nanoparticles in cancer cells and normal cells. Therefore, we are interested to investigate whether normal cells and cancer cells differentially respond to AgNPs, to examine the effect of both the cells which were treated with various concentrations of AgNPs and measured cell viability. After 24 h of treatment with different AgNP concentrations, the A549-treated cells showed a dose-dependent decrease in cell viability compared to that of the control group, whereas there is no significant difference between AgNP-treated L132 cells and control group (Figure 11). The most apparent and noticeable effect following exposure of cells to toxic materials is the alteration in the cell shape or morphology of the monolayer culture [108]. The cell viability assays shows that A549 cells have significant inhibitory effect of AgNPs and are more sensitive than L132 lung normal cells (Figure 11). Our studies are consistent with previous studies which show that AgNP exposure could induce the changes of cell shape, reduce cell viability, increase LDH release, and finally result in cell apoptosis and necrosis [48,51,53,109-111].
Figure 11

Effect of AgNPs on cell viability of L 132 and A549 cells. Cells were treated with various concentrations of AgNPs for 24 h, and cytotoxicity was determined by the MTT method. The results are expressed as the mean ± SD of three separate experiments each of which contained three replicates. Treated groups showed statistically significant differences from the control group by Student’s t-test (p < 0.05).

Effect of AgNPs membrane leakage

To investigate the effect of AgNPs on membrane integrity; L132 and A549 cells were treated with various concentrations of AgNPs for 24 h. The results suggest that cell membrane leakage was dose dependent and significantly affected (Figure 12). The results from the LDH assay were consistent with cell viability; with increasing concentrations of AgNPs, the cells became gradually more cytotoxic. The increase of LDH leakage was due to abrupt cell membrane lysis following cell death, which suggests that the membrane leakage was a consequence of the apoptosis [54]. Interestingly, AgNP shows more toxicity in A549 cells, whereas L132 cells have no significant leakage of membrane. The results suggest that AgNP is targeting on cancer cells rather than normal in given concentrations. Similarly, Hussain et al. [41] observed that BRL 3A rat liver cells exposed to AgNPs for 24 h resulted in a concentration-dependent increase in LDH leakage and exhibited significant cytotoxicity at 10–50 μg/mL. Park et al. [112] reported that AgNPs significantly affect membrane integrity in L929 fibroblasts. Song et al. [113] observed dose- and time-dependent reduction of cell viability and decreased the activities of superoxide dismutase and glutathione peroxides. Lee et al. [114] reported that the level of LDH was increased to 210% when cells were exposed to 48 h in a culture medium containing AgNPs at 100 μg/mL. Interestingly, Choi et al. [115] found that exposure to layered metal hydroxide (LMH), for 72 h, resulted in a remarkable concentration-dependent increase in LDH leakage from A549 and HOS cells, but not from L-132 and HeLa cells, suggesting that the membrane damage caused by LMH depends on the cell types. Similarly, we found that membrane damage was observed only A549 cells. We found that concentration of 30 μg/mL is sufficient to induce 50% cell death, which is found to be IC50. Therefore, this concentration was used for further analysis of ROS and apoptosis assay.
Figure 12

Effect of AgNPs on LDH release from L 132 and A549 cells. Lactate dehydrogenase (LDH) was measured by changes in optical density due to NAD+ reduction monitored at 490 nm, as described in materials and methods. The results are expressed as the mean ± SD of three separate experiments each of which contained three replicates. Treated groups showed statistically significant differences from the control group by Student’s t-test (p < 0.05).

AgNPs induce time-dependent ROS generation

Since nanoparticles like carbon nanotubes [116], LMH [115], AgNPs [49,56], zinc oxide nanoparticles [117], graphene, and graphene-related nanomaterials [118] are toxic due to oxidative stress and lead to increased apoptosis. We examined the ability of AgNPs to induce oxidative stress by measuring ROS with carboxy-H2DCFDA in L132 and A549 cells. The cells were treated with 30 μg/mL of AgNPs at various time points such as 0, 6, 12, and 24 h. The increase in fluorescence intensity is directly proportional to the generation of ROS. A549 cells exposed to 30 μg/mL AgNPs for 24 h showed a dose-dependent increase in fluorescence intensity, indicating the generation of ROS and oxidative stress (Figure 13), whereas L-132 cells showed a very weak fluorescence at 24 h indicating AgNPs could target selective toxicity to cancer cells. Similarly, Choi et al. [115] found selective ROS generation by LMH in A549 cells. Akhtar et al. [117] also found that zinc oxide nanoparticles produce significant toxicity via ROS generation in all cancer cells including HepG2, A549, and BEAS-2B except normal rat cells (astrocytes and hepatocytes). In many pathological condition, inflammation-induced oxidative stress and ROS also plays an important role in lipid peroxidation followed by membrane damage [119].
Figure 13

AgNPs induce generation of ROS in AgNP-treated L 132 and A549 cells. Fluorescence images of A549 (A) and L132 (B) cells without silver nanoparticles (AgNPs) (0) and cells treated with AgNPs 30 μg/mL and incubated at different time points. The image shows significant formation of hydrogen peroxide inside the A549 cells, whereas weak fluorescence was observed in L132 cells.

AgNPs induce mitochondrial-mediated apoptosis

Mitochondrial transmembrane potential (MTP) is an early event in apoptosis. JC-1 monomer assay was used to evaluate the effect of AgNPs in mitochondrial membrane permeability. Mitochondria-mediated apoptosis undergoes two major changes which include changes in the permeabilization of the outer mitochondrial membrane and the loss of the electro chemical gradient [120]. The permeabilization of the outer membrane is tightly regulated by a member of the Bcl-2 family. Membrane depolarization is mediated by the mitochondrial permeability transition pore. Prolonged mitochondrial permeability transition pore opening leads to a compromised outer mitochondrial membrane [120,121]. As shown in Figure 14, decreases in mitochondrial energy transduction were observed following treatment of AgNPs for 12 h, illustrated by disappearance of red fluorescence and emergence of green fluorescence in A549 cells, whereas the green fluorescence was very weak in L132 cells treated with AgNPs at the same concentration and same time, indicating that AgNPs could cause MTP collapse significantly higher in cancer cells than normal cells. These results suggest that AgNPs could induce apoptosis through a mitochondria-mediated apoptosis pathway. A similar observation was made in RAW264.7 cells with the tert-butyl hydroperoxide treatment-enhanced mitochondria-mediated apoptosis through failure of MTP [122]. Mitochondria play an important role in apoptosis, via the intrinsic apoptotic program. An intrinsic apoptotic pathway is the depolarization of the mitochondrial (mt) membrane. Depolarized mt is a result of the formation of mt permeability transition (PT) pores [123,124]. mt PT has been associated with various metabolic consequences such as halted functioning of the electron transport chain with associated elevation in ROS and decreased production of ATP [125]. Govender et al. [123] observed a significant increase in mt depolarization after AgNP treatment, with an accompanying decrease in ATP concentration. They concluded that the high levels of bax expression, high mt depolarization, and decreased ATP suggest that AgNP induces cellular apoptosis in cancerous lung cells via the intrinsic apoptotic pathway. Several studies also suggest that nanoparticles seem to be localized in mitochondria and cause oxidative stress as well as potentiate structural damage and eventually lead to toxicity to the cells [44,126-128].
Figure 14

AgNPs modulate mitochondrial transmembrane potential. Changes in mitochondrial transmembrane potential (MTP) was determined using the cationic fluorescent indicator, JC-1. Fluorescence images of control A549 cells and L132 cells (without silver nanoparticles (AgNPs)) and cells treated with AgNPs (30 μg/ml).The changes of mitochondrial membrane potential by AgNPs were obtained using fluorescence microscopy. JC-1 formed red-fluorescent J-aggregates in healthy A549 cells with high MTP, whereas A549 cells exposed to AgNPs had low MTP and, JC-1 existed as a monomer, showing green fluorescence. L132 cells exposed to AgNPs shows healthy and had high MTP.


We have demonstrated an easy, simple, and environmentally friendly approach to the synthesis of AgNPs using the leaf extract of A. princeps as a reducing and stabilizing agent. In this method, highly crystalline, spherical-shaped AgNPs with an average size of 20 nm were prepared without using any harmful reducing or capping agents. The phyto-molecules of the A. princeps extract were not only responsible for the reduction of AgNO3 but also function as capping agents to the surfaces of the AgNPs. The novel AgNPs show multifunctional effects against bacteria and human cancer cells, yet were biocompatible with normal lung cells. This suggests that AgNPs could contribute to develop therapeutic molecules for anticancer and anti-angiogenic. Interestingly, this comprehensive report describes the effect of AgNPs in bacteria and human cell types. Our results highlight a common and possible mechanism of cell death in bacteria and human cancer cells that is due to the generation of ROS, eventually leading to cell death. We believe that biologically prepared AgNPs could open a new avenue for various biomedical applications, particularly infections and cancer.



This work was supported by the KU-Research Professor Program of Konkuk University. Dr Sangiliyandi Gurunathan was supported by a Konkuk University KU-Full-Time Professorship. This work was carried out by Woo Jang-Choon project (PJ007849) from the Rural Development Administration (RDA), Republic of Korea.

Authors’ Affiliations

Department of Animal Biotechnology, Konkuk University
GS Institute of Bio and Nanotechnology


  1. Ju-Nam Y, Lead JR. Manufactured nanoparticles: an overview of their chemistry, interactions and potential environmental implications. Science Total Environment. 2008;400:396–414.View ArticleGoogle Scholar
  2. Nelson DJ, Strano M. Richard Smalley: saving the world with nanotechnology. Nat Nanotechnol. 2006;1:96–7.View ArticleGoogle Scholar
  3. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett. 2008;176:1–12.View ArticleGoogle Scholar
  4. Stensberg MC, Wei QS, McLamore ES, Porterfield DM, Wei A, Sepulveda MS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine. 2011;6:879–98.View ArticleGoogle Scholar
  5. Tran QH, Nguyen VQ, Le AT. Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives. Adv Nat Sci: Nanosci Nanotechnol. 2013;4:033001 (20 pp).Google Scholar
  6. Abdel-Mohsen AM, Hrdina R, Burgert L, Abdel-Rahman RM, Hasova M, Smejkalova D, et al. Antibacterial activity and cell viability of hyaluronan fiber with silver nanoparticles. Carbohydr Polym. 2013;92:1177–87.View ArticleGoogle Scholar
  7. Gnanadhas DP, Ben Thomas M, Thomas R, Raichur AM, Chakravortty D. Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo. Antimicrob Agents Chemother. 2013;57:4945–55.View ArticleGoogle Scholar
  8. Gurunathan S, Han JW, Kwon DN, Kim JH. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res Lett. 2014;9:373.View ArticleGoogle Scholar
  9. Gurunathan S, Kalishwaralal K, Vaidyanathan R, Deepak V, Pandian SRK, Muniyandi J, et al. Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloids Surfaces B-Biointerfaces. 2009;74:328–35.View ArticleGoogle Scholar
  10. Kalimuthu K, Babu RS, Venkataraman D, Bilal M, Gurunathan S. Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids Surfaces B-Biointerfaces. 2008;65:150–3.View ArticleGoogle Scholar
  11. Malik MA, O’Brien P, Revaprasadu N. A simple route to the synthesis of core/shell nanoparticles of chalcogenides. Chem Mater. 2002;14:2004–10.View ArticleGoogle Scholar
  12. Parikh RY, Singh S, Prasad BLV, Patole MS, Sastry M, Shouche YS. Extracellular synthesis of crystalline silver nanoparticles and molecular evidence of silver resistance from Morganella sp.: towards understanding biochemical synthesis mechanism. ChemBioChem. 2008;9:1415–22.View ArticleGoogle Scholar
  13. Thakkar KN, Mhatre SS, Parikh RY. Biological synthesis of metallic nanoparticles. Nanomedicine-Nanotechnology Biol Med. 2010;6:257–62.View ArticleGoogle Scholar
  14. Emerich DF, Thanos CG. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Biomol Eng. 2006;23:171–84.View ArticleGoogle Scholar
  15. Sintubin L, Verstraete W, Boon N. Biologically produced nanosilver: current state and future perspectives. Biotechnol Bioeng. 2012;109:2422–36.View ArticleGoogle Scholar
  16. Choi Y, Jeong Y, Chung H, Ito E, Hara M, Noh J. Formation of ordered self-assembled monolayers by adsorption of octylthiocyanates on Au(111). Langmuir. 2007;24:91–6.View ArticleGoogle Scholar
  17. Klaus T, Joerger R, Olsson E, Granqvist CG. Silver-based crystalline nanoparticles, microbially fabricated. Proc Natl Acad Sci U S A. 1999;96:13611–4.View ArticleGoogle Scholar
  18. Kalishwaralal K, Deepak V, Ram Kumar Pandian S, Kottaisamy M, BarathmaniKanth S, Kartikeyan B, et al. Biosynthesis of silver and gold nanoparticles using Brevibacterium casei. Colloids Surf B: Biointerfaces. 2010;77:257–62.View ArticleGoogle Scholar
  19. Suresh AK, Pelletier DA, Wang W, Moon JW, Gu B, Mortensen NP, et al. Silver nanocrystallites: biofabrication using Shewanella oneidensis, and an evaluation of their comparative toxicity on gram-negative and gram-positive bacteria. Environ Sci Technol. 2010;44:5210–5.View ArticleGoogle Scholar
  20. Ahmad A, Mukherjee P, Senapati S, Mandal D, Khan MI, Kumar R, et al. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surf B: Biointerfaces. 2003;28:313–8.View ArticleGoogle Scholar
  21. Fayaz M, Tiwary CS, Kalaichelvan PT, Venkatesan R. Blue orange light emission from biogenic synthesized silver nanoparticles using Trichoderma viride. Colloids Surf B: Biointerfaces. 2010;75:175–8.View ArticleGoogle Scholar
  22. Shankar SS, Ahmad A, Sastry M. Geranium leaf assisted biosynthesis of silver nanoparticles. Biotechnol Prog. 2003;19:1627–31.View ArticleGoogle Scholar
  23. Shankar SS, Rai A, Ahmad A, Sastry M. Controlling the optical properties of lemongrass extract synthesized gold nanotriangles and potential application in infrared-absorbing optical coatings. Chem Mater. 2005;17:566–72.View ArticleGoogle Scholar
  24. Shankar SS, Rai A, Ahmad A, Sastry M. Rapid synthesis of Au, Ag, and bimetallic Au core-Ag shell nanoparticles using Neem (Azadirachta indica) leaf broth. J Colloid Interface Sci. 2004;275:496–502.View ArticleGoogle Scholar
  25. Chandran SP, Chaudhary M, Pasricha R, Ahmad A, Sastry M. Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract. Biotechnol Prog. 2006;22:577–83.View ArticleGoogle Scholar
  26. Baishya D, Sharma N, Bora R. Green synthesis of silver nanoparticle using Bryophyllum pinnatum (Lam.) and monitoring their antibacterial activities. Scholars Res. Library. 2012;4:2098–104.Google Scholar
  27. Raut RW, Lakkakula JR, Kolekar NS, Mendhulkar VD, Kashid SB. Phytosynthesis of silver nanoparticle using Gliricidia sepium (Jacq.). Curr Nanosci. 2009;5:117–22.View ArticleGoogle Scholar
  28. Gardea-Torresdey JL, Gomez E, Peralta-Videa JR, Parsons JG, Troiani H, Jose-Yacaman M. Alfalfa sprouts: a natural source for the synthesis of silver nanoparticles. Langmuir. 2003;19:1357–61.View ArticleGoogle Scholar
  29. Das J, Velusamy P. Biogenic synthesis of antifungal silver nanoparticles using aqueous stem extract of banana. Nano Biomed Eng. 2013;5:34–8.Google Scholar
  30. Khalil NM, de Mattos AC, Carraro TCMM, Ludwig DB, Mainardes RM. Nanotechnological strategies for the treatment of neglected diseases. Curr Pharm Des. 2013;19:7316–29.View ArticleGoogle Scholar
  31. Umano K, Hagi Y, Nakahara K, Shoji A, Shibamoto T. Volatile chemicals identified in extracts from leaves of Japanese mugwort (Artemisia princeps Pamp). J Agric Food Chem. 2000;48:3463–9.View ArticleGoogle Scholar
  32. Kim YS, Lee JH, Kim MN, Lee WG, Kim JO. Volatile flavour compounds from raw mugwort leaves and parched mugwort. J Korean Soc Food Sci Nutr. 1994;23:261–4.Google Scholar
  33. Yun KW, Kil BS, Park JS. Identification of naturally occurring, chemicals from Artemis, princeps var, orientalis. Allelopathy J. 1994;1:95–104.Google Scholar
  34. Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect. 2009;59 Suppl 1:S4–16.View ArticleGoogle Scholar
  35. Parsonnet J. Bacterial infection as a cause of cancer. Environ Health Perspect. 1995;103 Suppl 8:263–8.View ArticleGoogle Scholar
  36. Chang AH, Parsonnet J. Role of bacteria in oncogenesis. Clin Microbiol Rev. 2010;23:837−+.View ArticleGoogle Scholar
  37. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195–206.View ArticleGoogle Scholar
  38. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207–15.View ArticleGoogle Scholar
  39. Sukumar UK, Bhushan B, Dubey P, Matai I, Sachdev A, Packirisamy G. Emerging applications of nanoparticles for lung cancer diagnosis and therapy. Int Nano Lett. 2013;3:45.View ArticleGoogle Scholar
  40. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.View ArticleGoogle Scholar
  41. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol Vitro. 2005;19:975–83.View ArticleGoogle Scholar
  42. Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci. 2006;92:456–63.View ArticleGoogle Scholar
  43. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci. 2005;88:412–9.View ArticleGoogle Scholar
  44. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Physical Chem B. 2008;112:13608–19.View ArticleGoogle Scholar
  45. Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 2011;85:743–50.View ArticleGoogle Scholar
  46. Tripathi RM, Rana D, Shrivastav A, Singh RP, Shrivastavd BR. Biogenic synthesis of silver nanoparticles using Saraca indica leaf extract and evaluation of their antibacterial activity. Nano Biomed Eng. 2013;5:50–6.Google Scholar
  47. Abdeen S, Rimal Isaac RS, Geo S, Sornalekshmi S, Rose A, Praseetha PK. Evaluation of antimicrobial activity of biosynthesized iron and silver nanoparticles using the fungi Fusarium oxysporum and Actinomycetes sp. On human pathogens. Nano Biomed Eng. 2013;5:39–45.Google Scholar
  48. Li C, Wang XS, Chen F, Zhang CL, Zhi X, Wang K, et al. The antifungal activity of graphene oxide-silver nanocomposites. Biomaterials. 2013;34:3882–90.View ArticleGoogle Scholar
  49. Gurunathan S, Raman J, Malek NA, John PA, Vikineswary S. Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells. Int J Nanomedicine. 2013;8:4399–413.Google Scholar
  50. Arora S, Jain J, Rajwade JM, Paknikar KM. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett. 2008;179:93–100.View ArticleGoogle Scholar
  51. AshaRani PV, Mun GLK, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3:279–90.View ArticleGoogle Scholar
  52. Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, et al. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol Vitro. 2009;23:1076–84.View ArticleGoogle Scholar
  53. Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett. 2009;190:156–62.View ArticleGoogle Scholar
  54. Gurunathan S, Han JW, Eppakayala V, Dayem AA, Kwon DN, Kim JH. Biocompatibility effects of biologically synthesized graphene in primary mouse embryonic fibroblast cells. Nanoscale Res Lett. 2013;8:393.View ArticleGoogle Scholar
  55. Yonezawa H, Osaki T, Kurata S, Zaman C, Hanawa T, Kamiya S. Assessment of in vitro biofilm formation by Helicobacter pylori. J Gastroenterol Hepatol. 2010;25 Suppl 1:S90–4.View ArticleGoogle Scholar
  56. Gurunathan S, Han JW, Dayem AA, Eppakayala V, Kim JH. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa. Int J Nanomedicine. 2012;7:5901–14.View ArticleGoogle Scholar
  57. Shameli K, Ahmad MB, Yunus WM, Ibrahim NA, Gharayebi Y, Sedaghat S. Synthesis of silver/montmorillonite nanocomposites using gamma-irradiation. Int J Nanomedicine. 2010;5:1067–77.Google Scholar
  58. Awwad A, Salem N, Abdeen A. Green synthesis of silver nanoparticles using carob leaf extract and its antibacterial activity. Int J Industr Chem. 2013;4:1–6.View ArticleGoogle Scholar
  59. Mukherjee S, Chowdhury D, Kotcherlakota R, Patra S, Vinothkumar B, Bhadra MP, et al. Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system). Theranostics. 2014;4:316–35.View ArticleGoogle Scholar
  60. Tavitian BA, Nabedryk E, Mäntele W, Breton J. Light-induced Fourier transform infrared (FTIR) spectroscopic investigations of primary reactions in photosystem I and photosystem II. FEBS Lett. 1986;201:151–7.View ArticleGoogle Scholar
  61. Kong J, Yu S. Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochimica Et Biophysica Sinica. 2007;39:549–59.View ArticleGoogle Scholar
  62. Loo YY, Chieng BW, Nishibuchi M, Radu S. Synthesis of silver nanoparticles by using tea leaf extract from Camellia sinensis. Int J Nanomedicine. 2012;7:4263–7.Google Scholar
  63. Singhal G, Bhavesh R, Kasariya K, Sharma AR, Singh RP. Biosynthesis of silver nanoparticles using Ocimum sanctum (Tulsi) leaf extract and screening its antimicrobial activity. J Nanoparticle Res. 2011;13:2981–8.View ArticleGoogle Scholar
  64. Macdonald IDG, Smith WE. Orientation of cytochrome c adsorbed on a citrate-reduced silver colloid surface. Langmuir. 1996;12:706–13.View ArticleGoogle Scholar
  65. Gole A, Dash C, Ramakrishnan V, Sainkar SR, Mandale AB, Rao M, et al. Pepsin-gold colloid conjugates: preparation, characterization, and enzymatic activity. Langmuir. 2001;17:1674–9.View ArticleGoogle Scholar
  66. Philip D, Unni C. Extracellular biosynthesis of gold and silver nanoparticles using Krishna tulsi (Ocimum sanctum) leaf. Physica E-Low-Dimensional Systems & Nanostructures. 2011;43:1318–22.View ArticleGoogle Scholar
  67. Bar H, Bhui DK, Sahoo GP, Sarkar P, De SP, Misra A. Green synthesis of silver nanoparticles using latex of Jatropha curcas. Colloids and Surfaces a-Physicochemical and Engineering Aspects. 2009;339:134–9.View ArticleGoogle Scholar
  68. Pasupuleti VR, Prasad C, Shiekh RA, Balam SK, Narasimhulu G, Reddy CS, et al. Biogenic silver nanoparticles using Rhinacanthus nasutus leaf extract: synthesis, spectral analysis, and antimicrobial studies. Int J Nanomedicine. 2013;8:3355–64.View ArticleGoogle Scholar
  69. Rupiasih NN, Avinash A, Suresh G, Vidyasagar PB. Green synthesis of silver nanoparticles using latex extract of Thevetia peruviana: a novel approach towards poisonous plant utilization. J Physics: Conference Series. 2013;423:012032.Google Scholar
  70. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci. 2006;90:296–303.View ArticleGoogle Scholar
  71. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci. 2008;101:239–53.View ArticleGoogle Scholar
  72. Umoren SA, Obot IB, Gasem ZM. Green synthesis and characterization of silver nanoparticles using red apple (Malus domestica) fruit extract at room temperature. J Materials Environmental Sci. 2014;5:907–14.Google Scholar
  73. IARC. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.Google Scholar
  74. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–44.View ArticleGoogle Scholar
  75. Haesebrouck F, Pasmans F, Flahou B, Chiers K, Baele M, Meyns T, et al. Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health. Clin Microbiol Rev. 2009;22:202–23. Table of Contents.View ArticleGoogle Scholar
  76. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3:95–101.View ArticleGoogle Scholar
  77. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622–7.View ArticleGoogle Scholar
  78. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm. 2009;6:1388–401.View ArticleGoogle Scholar
  79. Parashar UK, Kumar V, Bera T, Saxena PS, Nath G, Srivastava SK, et al. Study of mechanism of enhanced antibacterial activity by green synthesis of silver nanoparticles. Nanotechnology. 2011;22:415104.View ArticleGoogle Scholar
  80. Li WR, Xie XB, Shi QS, Zeng HY, Ou-Yang YS, Chen YB. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol. 2010;85:1115–22.View ArticleGoogle Scholar
  81. Anthony KJP, Murugan M, Gurunathan S. Biosynthesis of silver nanoparticles from the culture supernatant of Bacillus marisflavi and their potential antibacterial activity. J Industrial Engineering Chemistry. 2014;20:1505–10.View ArticleGoogle Scholar
  82. Hwang IS, Hwang JH, Choi H, Kim KJ, Lee DG. Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. J Med Microbiol. 2012;61:1719–26.View ArticleGoogle Scholar
  83. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275:177–82.View ArticleGoogle Scholar
  84. Su HL, Chou CC, Hung DJ, Lin SH, Pao IC, Lin JH, et al. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials. 2009;30:5979–87.View ArticleGoogle Scholar
  85. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95–108.View ArticleGoogle Scholar
  86. Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids and Surfaces B-Biointerfaces. 2010;79:340–4.View ArticleGoogle Scholar
  87. Khan MM, Ansari SA, Amal MI, Lee J, Cho MH. Highly visible light active Ag@TiO2 nanocomposites synthesized using an electrochemically active biofilm: a novel biogenic approach. Nanoscale. 2013;5:4427–35.View ArticleGoogle Scholar
  88. Masurkar SA, Chaudhari PR, Shidore VB, Kamble SP. Effect of biologically synthesised silver nanoparticles on Staphylococcus aureus biofilm quenching and prevention of biofilm formation. IET Nanobiotechnol. 2012;6:110–4.View ArticleGoogle Scholar
  89. Martinez-Gutierrez F, Boegli L, Agostinho A, Sanchez EM, Bach H, Ruiz F, et al. Anti-biofilm activity of silver nanoparticles against different microorganisms. Biofouling. 2013;29:651–60.View ArticleGoogle Scholar
  90. Ninganagouda S, Rathod V, Singh D, Hiremath J, Singh AK, Mathew J, et al. Growth kinetics and mechanistic action of reactive oxygen species released by silver nanoparticles from Aspergillus niger on Escherichia coli. Biomed Research International. 2014;2014:753419.View ArticleGoogle Scholar
  91. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 2000;52:662–8.View ArticleGoogle Scholar
  92. Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol. 2008;74:2171–8.View ArticleGoogle Scholar
  93. Matsumura Y, Yoshikata K, Kunisaki S, Tsuchido T. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol. 2003;69:4278–81.View ArticleGoogle Scholar
  94. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16:2346–53.View ArticleGoogle Scholar
  95. Yamanaka M, Hara K, Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol. 2005;71:7589–93.View ArticleGoogle Scholar
  96. Dwyer DJ, Camacho DM, Kohanski MA, Callura JM, Collins JJ. Antibiotic-induced bacterial cell death exhibits physiological and biochemical hallmarks of apoptosis. Mol Cell. 2012;46:561–72.View ArticleGoogle Scholar
  97. Kohanski MA, DePristo MA, Collins JJ. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell. 2010;37:311–20.View ArticleGoogle Scholar
  98. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130:797–810.View ArticleGoogle Scholar
  99. Morones-Ramirez JR, Winkler JA, Spina CS, Collins JJ. Silver enhances antibiotic activity against gram-negative bacteria. Sci Transl Med. 2013;5:190ra181.View ArticleGoogle Scholar
  100. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–57.View ArticleGoogle Scholar
  101. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306.View ArticleGoogle Scholar
  102. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205–19.View ArticleGoogle Scholar
  103. Dwyer DJ, Kohanski MA, Hayete B, Collins JJ. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol. 2007;3:91.View ArticleGoogle Scholar
  104. Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G, Collins JJ. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell. 2008;135:679–90.View ArticleGoogle Scholar
  105. Park JH, Kim EJ, Jang HY, Shim H, Lee KK, Jo HJ, et al. Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases. Oncol Rep. 2008;20:379–84.Google Scholar
  106. Foster KA, Galeffi F, Gerich FJ, Turner DA, Muller M. Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Prog Neurobiol. 2006;79:136–71.View ArticleGoogle Scholar
  107. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.View ArticleGoogle Scholar
  108. Sriram MI, Kalishwaralal K, Barathmanikanth S, Gurunathani S. Size-based cytotoxicity of silver nanoparticles in bovine retinal endothelial cells. Nanoscience Methods. 2012;1:56–77.View ArticleGoogle Scholar
  109. Almofti MR, Ichikawa T, Yamashita K, Terada H, Shinohara Y. Silver ion induces a cyclosporine a-insensitive permeability transition in rat liver mitochondria and release of apoptogenic cytochrome C. J Biochem. 2003;134:43–9.View ArticleGoogle Scholar
  110. Kim YJ, Yang SI, Ryu JC. Cytotoxicity and genotoxicity of nano-silver in mammalian cell lines. Molecular Cellular Toxicol. 2010;6:119–25.View ArticleGoogle Scholar
  111. Zhang T, Wang L, Chen Q, Chen C. Cytotoxic potential of silver nanoparticles. Yonsei Med J. 2014;55:283–91.View ArticleGoogle Scholar
  112. Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briede JJ, et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials. 2011;32:9810–7.View ArticleGoogle Scholar
  113. Song XL, Li B, Xu K, Liu J, Ju W, Wang J, et al. Cytotoxicity of water-soluble mPEG-SH-coated silver nanoparticles in HL-7702 cells. Cell Biol Toxicol. 2012;28:225–37.View ArticleGoogle Scholar
  114. Lee YS, Kim DW, Lee YH, Oh JH, Yoon S, Choi MS, et al. Silver nanoparticles induce apoptosis and G2/M arrest via PKC zeta-dependent signaling in A549 lung cells. Arch Toxicol. 2011;85:1529–40.View ArticleGoogle Scholar
  115. Choi SJ, Oh JM, Choy JH. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J Inorg Biochem. 2009;103:463–71.View ArticleGoogle Scholar
  116. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823–39.View ArticleGoogle Scholar
  117. Akhtar MJ, Ahamed M, Kumar S, Khan MAM, Ahmad J, Alrokayan SA. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine. 2012;7:845–57.Google Scholar
  118. Gurunathan S, Han JW, Dayem AA, Eppakayala V, Park MR, Kwon DN, et al. Antibacterial activity of dithiothreitol reduced graphene oxide. J Industrial Engineering Chemistry. 2013;19:1280–8.View ArticleGoogle Scholar
  119. Pulskamp K, Diabate S, Krug HF. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett. 2007;168:58–74.View ArticleGoogle Scholar
  120. Kimata M, Matoba S, Iwai-Kanai E, Nakamura H, Hoshino A, Nakaoka M, et al. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress. Am J Physiology-Heart Circulatory Physiology. 2010;299:H1908–16.View ArticleGoogle Scholar
  121. Rasola A, Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis. 2007;12:815–33.View ArticleGoogle Scholar
  122. Han L, Du LB, Kumar A, Jia HY, Liang XJ, Tian Q, et al. Inhibitory effects of trolox-encapsulated chitosan nanoparticles on tert-butylhydroperoxide induced RAW264.7 apoptosis. Biomaterials. 2012;33:8517–28.View ArticleGoogle Scholar
  123. Govender R, Phulukdaree A, Gengan RM, Anand K, Chuturgoon AA. Silver nanoparticles of Albizia adianthifolia: the induction of apoptosis in human lung carcinoma cell line. J Nanobiotechnology. 2013;11:5.View ArticleGoogle Scholar
  124. Hirsch T, Marzo I, Kroemer G. Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep. 1997;17:67–76.View ArticleGoogle Scholar
  125. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001;15:2922–33.Google Scholar
  126. Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi H, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2:2121–34.View ArticleGoogle Scholar
  127. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006;6:1794–807.View ArticleGoogle Scholar
  128. Derfus AM, Chan WCW, Bhatia SN. Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv Mater. 2004;16:961−+.View ArticleGoogle Scholar


© Gurunathan et al.; licensee Springer. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.